Topical Collection on Inflammatory Bowel Disease
In this topical collection (76 articles)
-
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Endoscopic Disease Activity in Inflammatory Bowel Disease
Shara Nguyen Ket, Rebecca Palmer, Simon Travis Article:50 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Approach to the Patient with Mild Crohn’s Disease: a 2016 Update
Frank I. Scott, Gary R. Lichtenstein Article:50 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Monitoring for Extra-Intestinal Cancers in IBD
H. Sifuentes, S. Kane Article:42 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Quality Improvement Initiatives in Inflammatory Bowel Disease
Sameer K. Berry, Corey A. Siegel, Gil Y. Melmed Article:41 -
Inflammatory Bowel Diseases (S Hanauer, Section Editor)
Evolution of Clinical Trials in Inflammatory Bowel Diseases
Siddharth Singh Article:41 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Evolving Epidemiology of IBD
Joseph W. Windsor, Gilaad G. Kaplan Article:40 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
De-escalation of Therapy in Inflammatory Bowel Disease
Catarina Frias Gomes, Jean-Frédéric Colombel… Article:35 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Practical Approaches to “Top–Down” Therapies for Crohn’s Disease
Aranzazu Jauregui Amezaga, Gert Van Assche Article:35 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Optimizing Biologic Agents in Ulcerative Colitis and Crohn’s Disease
Aoibhlinn O’Toole, Alan C. Moss Article:32 -
Inflammatory Bowel Disease (M Regueiro, Section Editor)
Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate)
Lindsey Sattler, Stephen B Hanauer, Lisa Malter Article:30 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Positioning Therapy for Ulcerative Colitis
Ari Grinspan, Asher Kornbluth Article:29 -
Inflammatory Bowel Disease (SB Hanauer, Section Editor)
Clinical Utility of Biomarkers in IBD
Gerhard Rogler, Luc Biedermann Article:26 -
Inflammatory Bowel Disease (M Regueiro, Section Editor)
The Management of the Hospitalized Ulcerative Colitis Patient, the Medical—Surgical Conundrum
Michele Carvello, Joseph Watfah, Antonino Spinelli Article:25 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
A Practical Approach to Preventing Postoperative Recurrence in Crohn’s Disease
Jana G. Hashash, Miguel Regueiro Article:25 -
Inflammatory Bowel Diseases (S Hanauer, Section Editor)
Health Maintenance in Inflammatory Bowel Disease
Fazia A. Mir, Sunanda V. Kane Article:23 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
The Role of Diet in Inflammatory Bowel Disease
Raina Shivashankar, James D. Lewis Article:22 -
Inflammatory Bowel Disease (S Hananauer, Section Editor)
Novel Non-biologic Targets for Inflammatory Bowel Disease
Tushar Shukla, Bruce E. Sands Article:22 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Modifiable Environmental Factors in Inflammatory Bowel Disease
Kristin E. Burke, Christine Boumitri… Article:21 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Next-Generation Therapeutics for IBD
Mark Löwenberg, Geert D’Haens Article:21 -
Inflammatory Bowel Disease (S Hanauer, Section Editor)
Integrating Adolescents and Young Adults into Adult-Centered Care for IBD
Itishree Trivedi, Jane L. Holl, Stephen Hanauer… Article:21
![Current Gastroenterology Reports](https://static-content.springer.com/cover/journal/11894/0/0.jpg)
Continue reading...
To view the rest of this content please follow the download PDF link above.